ARKO Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Earnings per Share (Tables)

Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of Basic and Diluted Net Income Per Share of Common Stock

The following table sets forth the computation of basic and diluted net income (loss) per share of common stock:


	For the Three Months Ended March 31,
	2022			2021
	(in thousands)
Net income (loss) available to common stockholders	$	821		$	(16,138	)
Change in fair value of Ares Put Option		(1,062	)		—
Net loss available to common stockholders after assumed conversions	$	(241	)	$	(16,138	)

Weighted average common shares outstanding — Basic		124,301			124,361
Effect of dilutive securities:
Restricted share units		4			—
Ares Put Option		1,128			—
Weighted average common shares outstanding — Diluted		125,433			124,361
Net income (loss) per share available to common stockholders — Basic	$	0.01		$	(0.13	)
Net loss per share available to common stockholders — Diluted	$	(0.00	)	$	(0.13	)

Schedule of Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share

The following potential shares of common stock have been excluded from the computation of diluted net income (loss) per share because their effect would have been antidilutive:


	As of March 31,
	2022		2021
	(in thousands)
Stock options		897		126
Ares warrants		1,100		1,100
Public and Private warrants		17,333		17,333
Series A redeemable preferred stock		8,347		8,333
Restricted share units		—		1,511
Ares Put Option		—	*

* Refer to the description of this instrument in Note 8.